Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Change in Accured Expenses (2016 - 2025)

Dare Bioscience's Change in Accured Expenses history spans 11 years, with the latest figure at -$1.2 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 171.99% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$2.3 million, down 532.13%, while the annual FY2025 figure was -$2.3 million, 532.13% down from the prior year.
  • Change in Accured Expenses reached -$1.2 million in Q4 2025 per DARE's latest filing, down from -$618168.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $6.8 million in Q4 2022 to a low of -$8.3 million in Q4 2023.
  • Average Change in Accured Expenses over 5 years is -$134712.3, with a median of -$418156.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: soared 3809.3% in 2021, then crashed 1024.84% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$640500.0 in 2021, then soared by 1155.06% to $6.8 million in 2022, then plummeted by 222.41% to -$8.3 million in 2023, then surged by 120.9% to $1.7 million in 2024, then crashed by 171.99% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Change in Accured Expenses are -$1.2 million (Q4 2025), -$618168.0 (Q3 2025), and $695961.0 (Q2 2025).